Dasher Neuroscience Holdings (ROCO:7829) Total Equity: NT$984.02 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7829 Dasher Neuroscience Holdings Inc ROCO:7829
14 GF Score
Price NT$39.00
! 2 Warning Signs
View Full Analysis

What is Dasher Neuroscience Holdings Total Equity?

Dasher Neuroscience Holdings ROCO:7829 -2.86% 14 Total Equity is NT$984.02 Mil as of Dec. 2025. GuruFocus rates ROCO:7829 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Dasher Neuroscience Holdings's total equity for the quarter that ended in Dec. 2025 was NT$984.02 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Dasher Neuroscience Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for Dasher Neuroscience Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dasher Neuroscience Holdings Total Equity Chart

Dasher Neuroscience Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Equity
17.76 335.74 626.09 984.02

Dasher Neuroscience Holdings Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial 335.74 0.00 626.09 443.97 984.02
ROCO:7829
14GF Score
Dasher Neuroscience Holdings Inc ROCO:7829
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dasher Neuroscience Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Dasher Neuroscience Holdings's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1017.481-33.459
=984.02

Dasher Neuroscience Holdings's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1017.481-33.459
=984.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$984.02 Mil mean?
Dasher Neuroscience Holdings (ROCO:7829) has a Total Equity of NT$984.02 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Dasher Neuroscience Holdings and its competitors.
Is Dasher Neuroscience Holdings' Total Equity too high?
Dasher Neuroscience Holdings' current Total Equity is NT$984.02 Mil. Overall, Dasher Neuroscience Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Dasher Neuroscience Holdings' Total Equity compare to ZTS and UTHR?
Dasher Neuroscience Holdings' Total Equity of NT$984.02 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Dasher Neuroscience Holdings and its competitors. Dasher Neuroscience Holdings's current Total Equity is NT$984.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dasher Neuroscience Holdings stock overvalued right now?
Dasher Neuroscience Holdings (ROCO:7829) has a current Total Equity of NT$984.02 Mil. The current Total Equity is NT$984.02 Mil. Dasher Neuroscience Holdings' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Dasher Neuroscience Holdings (ROCO:7829), the current Total Equity is NT$984.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dasher Neuroscience Holdings Business Description

Address Park Street, 17th Floor., No.3, Nangang District, Taipei, TWN, 115603
Yoda Pharmaceuticals Inc is a pharmaceutical company specializing in using AI technology to develop drugs targeting Central Nervous System (CNS) disorders. The group provides solutions for Neurology, Neuropsychiatry, and Cerebrovascular Disease.
14GF Score

Get the complete analysis for ROCO:7829

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$39.00
Price